Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • LinaGallego
    Junior Member
    • Apr 2016
    • 1

    Discrepancies between UCSC and RefSeq transcripts

    Hello everybody,

    I have found the following confusing situation:
    Human CELF2 gene contains a group of 14 UCSC transcripts, but only 4 RefSeq transcrip IDs are described for this gene. The point is that several UCSC transcripts are surprisingly assigned to the same RefSeq transcript ID, despite the fact that each UCSC transcript is characterized by a unique set of exons and splice sites, so the final product is clearly not the same between them.

    I would really appreciate if anyone could help me to understand this discrepancy, since it is very important for my work to define the different contributions of CELF2 isoforms to a particular phenotype.

    Here is one example of what I have just talked about, two different transcript (two completely different transcripts with the same RefSeq NM_001083591):

    Human Gene CELF2 (uc010qbk.1) Description and Page Index
    RefSeq Summary (NM_001083591)
    Position: chr10:11,206,993-11,330,515 Size: 123,523 Total Exon Count: 8 Strand: +


    Human Gene CELF2 (uc001ikk.2) Description and Page Index
    RefSeq Summary (NM_001083591
    Position: chr10:11,059,893-11,374,605 Size: 314,713 Total Exon Count: 14 Strand: +


    Thanks a lot for any help!
  • mastal
    Senior Member
    • Mar 2009
    • 666

    #2
    Sorry if this adds even more confusion to your situation.

    Have a look at Ensembl and see how many Ensembl transcript IDs map to this gene, and how they compare to the UCSC and RefSeq transcripts.

    Comment

    • mbblack
      Senior Member
      • Aug 2009
      • 245

      #3
      Directly quoted from the RefSeq FAQ (http://www.ncbi.nlm.nih.gov/books/NBK50679/)

      Why are some splice variants for my favorite gene missing in the RefSeq set?

      RefSeq records that represent alternately spliced transcript variants are provided when there is experimental and/or published evidence in support of the full-length nature of the product. When transcript alignments (to the assembled genome) indicate that there is alternate splicing no assumption is made about the naturally-occurring combination(s) of alternate exons in the absence of full-length support. As a consequence, alternately spliced products are underrepresented in the RefSeq collection.

      Requests to review additional transcript variants for a gene, and their possible representation in RefSeq, can be made using the Gene and RefSeq Feedback form. We encourage research groups to submit primary sequence data representing alternatively spliced transcripts to the INSDC.
      Michael Black, Ph.D.
      ScitoVation LLC. RTP, N.C.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        Yesterday, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM
      • GATTACAT
        Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
        by GATTACAT
        Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
        07-01-2026, 11:43 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 10:04 AM
      0 responses
      10 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      7 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-07-2026, 11:05 AM
      0 responses
      12 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-02-2026, 11:08 AM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Working...